The TEVAR Center

Filter Your Results

 

News

 

Medtronic Presents 1-Year Valiant Navion and 4-Year ANCHOR Registry Outcomes

November 22, 2019 -- Medtronic announced the presentation of 1-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and 4-…

Terumo Acquires Aortica Corporation to Further Bolster Its Vascular Graft Portfolio

November 20, 2019 -- Terumo Corporation announced the acquisition of Aortica Corporation, which developed the AortaFit automated case planning software to match fenestrations …

TiGER Registry Commences to Evaluate Terumo Aortic’s Portfolio of Thoracic and Abdominal EVAR Devices

November 18, 2019 -- Terumo Aortic announced the launch of the company’s global endovascular registry know as TiGER (Terumo Aortic Global Endovascular Registry). The stu…

Endospan’s Nexus Arch Branch Stent Graft System Studied at 2 Years

November 5, 2019 -- VIVA Physicians announced that 2-year results from a prospective, multicenter, premarket study composed of 25 patients (mean age, 73 years) treated with th…

Medtronic’s Valiant Navion TEVAR Device Approved and Launched in Japan

October 31, 2019 -- Medtronic announced the launch of the Valiant Navion thoracic stent graft in Japan, where the Ministry of Health, Labour and Welfare granted it Shonin appr…

Five-Year STABLE I Results Reported for Cook Medical’s Zenith System to Treat Complicated Type B Aortic Dissections

October 15, 2019 -- The final 5-year results from STABLE I were published by Joseph V. Lombardi, MD, et al in Journal of Vascular Surgery (2019;70:1072 -- 1081). STABLE I i…

Medtronic Gains FDA Breakthrough Device Designations for Valiant TAAA and Valiant Navion LSA Systems

October 8, 2019 -- Medtronic announced the receipt of FDA Breakthrough Device designations for the company’s Valiant thoracoabdominal aortic aneurysm (TAAA) stent graft …

Terumo Aortic Completes Enrollment of RelayPro United States Pivotal Trial

September 26, 2019 -- Terumo Aortic announced the completion of enrollment of the RelayPro pivotal trial in the United States. RelayPro is a low-profile, next-generation thora…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.